375 related articles for article (PubMed ID: 26255596)
1. Glycoprotein130 (Gp130)/interleukin-6 (IL-6) signalling in osteoclasts promotes bone formation in periosteal and trabecular bone.
Johnson RW; McGregor NE; Brennan HJ; Crimeen-Irwin B; Poulton IJ; Martin TJ; Sims NA
Bone; 2015 Dec; 81():343-351. PubMed ID: 26255596
[TBL] [Abstract][Full Text] [Related]
2. The primary function of gp130 signaling in osteoblasts is to maintain bone formation and strength, rather than promote osteoclast formation.
Johnson RW; Brennan HJ; Vrahnas C; Poulton IJ; McGregor NE; Standal T; Walker EC; Koh TT; Nguyen H; Walsh NC; Forwood MR; Martin TJ; Sims NA
J Bone Miner Res; 2014 Jun; 29(6):1492-505. PubMed ID: 24339143
[TBL] [Abstract][Full Text] [Related]
3. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures.
Romas E; Udagawa N; Zhou H; Tamura T; Saito M; Taga T; Hilton DJ; Suda T; Ng KW; Martin TJ
J Exp Med; 1996 Jun; 183(6):2581-91. PubMed ID: 8676079
[TBL] [Abstract][Full Text] [Related]
4. CathepsinKCre mediated deletion of βcatenin results in dramatic loss of bone mass by targeting both osteoclasts and osteoblastic cells.
Ruiz P; Martin-Millan M; Gonzalez-Martin MC; Almeida M; González-Macias J; Ros MA
Sci Rep; 2016 Nov; 6():36201. PubMed ID: 27804995
[TBL] [Abstract][Full Text] [Related]
5. gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation.
Standal T; Johnson RW; McGregor NE; Poulton IJ; Ho PW; Martin TJ; Sims NA
J Endocrinol; 2014 Nov; 223(2):181-90. PubMed ID: 25228504
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-11 receptor signaling is required for normal bone remodeling.
Sims NA; Jenkins BJ; Nakamura A; Quinn JM; Li R; Gillespie MT; Ernst M; Robb L; Martin TJ
J Bone Miner Res; 2005 Jul; 20(7):1093-102. PubMed ID: 15940362
[TBL] [Abstract][Full Text] [Related]
7. The Effects of Androgens on Murine Cortical Bone Do Not Require AR or ERα Signaling in Osteoblasts and Osteoclasts.
Ucer S; Iyer S; Bartell SM; Martin-Millan M; Han L; Kim HN; Weinstein RS; Jilka RL; O'Brien CA; Almeida M; Manolagas SC
J Bone Miner Res; 2015 Jul; 30(7):1138-49. PubMed ID: 25704845
[TBL] [Abstract][Full Text] [Related]
8. Cell-specific paracrine actions of IL-6 family cytokines from bone, marrow and muscle that control bone formation and resorption.
Sims NA
Int J Biochem Cell Biol; 2016 Oct; 79():14-23. PubMed ID: 27497989
[TBL] [Abstract][Full Text] [Related]
9. Expression of IL-6 receptor and GP130 in mouse bone marrow cells during osteoclast differentiation.
Gao Y; Morita I; Maruo N; Kubota T; Murota S; Aso T
Bone; 1998 May; 22(5):487-93. PubMed ID: 9600782
[TBL] [Abstract][Full Text] [Related]
10. IL-6 trans-signalling mediates trabecular, but not cortical, bone loss after ovariectomy.
Lazzaro L; Tonkin BA; Poulton IJ; McGregor NE; Ferlin W; Sims NA
Bone; 2018 Jul; 112():120-127. PubMed ID: 29679733
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 deletion stimulates revascularization and new bone formation following ischemic osteonecrosis in a murine model.
Kuroyanagi G; Adapala NS; Yamaguchi R; Kamiya N; Deng Z; Aruwajoye O; Kutschke M; Chen E; Jo C; Ren Y; Kim HKW
Bone; 2018 Nov; 116():221-231. PubMed ID: 30125727
[TBL] [Abstract][Full Text] [Related]
12. Expression levels of gp130 in bone marrow stromal cells determine the magnitude of osteoclastogenic signals generated by IL-6-type cytokines.
O'Brien CA; Lin SC; Bellido T; Manolagas SC
J Cell Biochem; 2000 Sep; 79(4):532-41. PubMed ID: 10996844
[TBL] [Abstract][Full Text] [Related]
13. Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism.
Kang KS; Hong JM; Horan DJ; Lim KE; Bullock WA; Bruzzaniti A; Hann S; Warman ML; Robling AG
Bone; 2019 Mar; 120():166-175. PubMed ID: 30409757
[TBL] [Abstract][Full Text] [Related]
14. Cortical bone maturation in mice requires SOCS3 suppression of gp130/STAT3 signalling in osteocytes.
Walker EC; Truong K; McGregor NE; Poulton IJ; Isojima T; Gooi JH; Martin TJ; Sims NA
Elife; 2020 May; 9():. PubMed ID: 32458800
[TBL] [Abstract][Full Text] [Related]
15. Osteoclasts are present in gp130-deficient mice.
Kawasaki K; Gao YH; Yokose S; Kaji Y; Nakamura T; Suda T; Yoshida K; Taga T; Kishimoto T; Kataoka H; Yuasa T; Norimatsu H; Yamaguchi A
Endocrinology; 1997 Nov; 138(11):4959-65. PubMed ID: 9348227
[TBL] [Abstract][Full Text] [Related]
16. gp130 signaling in bone cell biology: multiple roles revealed by analysis of genetically altered mice.
Sims NA
Mol Cell Endocrinol; 2009 Oct; 310(1-2):30-9. PubMed ID: 18805458
[TBL] [Abstract][Full Text] [Related]
17. IL-1 plays an important role in the bone metabolism under physiological conditions.
Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
[TBL] [Abstract][Full Text] [Related]
18. The soluble interleukin-6 receptor is a mediator of hematopoietic and skeletal actions of parathyroid hormone.
Cho SW; Pirih FQ; Koh AJ; Michalski M; Eber MR; Ritchie K; Sinder B; Oh S; Al-Dujaili SA; Lee J; Kozloff K; Danciu T; Wronski TJ; McCauley LK
J Biol Chem; 2013 Mar; 288(10):6814-25. PubMed ID: 23297399
[TBL] [Abstract][Full Text] [Related]
19. Surface-specific effects of a PPARgamma agonist, darglitazone, on bone in mice.
Li M; Pan LC; Simmons HA; Li Y; Healy DR; Robinson BS; Ke HZ; Brown TA
Bone; 2006 Oct; 39(4):796-806. PubMed ID: 16759917
[TBL] [Abstract][Full Text] [Related]
20. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]